Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors
Clinical trial NCT04628780 · TERMINATED
Trial details
- NCT number
- NCT04628780
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2023-05-03
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.